This is an increase of 72 owner(s) or 31.58% in the last quarter. Average portfolio weight of all funds dedicated to PRAX is 0.24%, an increase of 9.83%. Total shares owned by institutions ...

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of ...

Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Truist Financial from $175.00 to $85.00 in a research note released on Monday morning,Benzinga reports.

Looking at options history for Praxis Precision Medicine (NASDAQ:PRAX) we detected 39 trades. If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened ...